Xtl Biopharmaceuticals (XTLB) Total Liabilities (2009 - 2025)
Xtl Biopharmaceuticals (XTLB) reported Total Liabilities of $420,000 for the quarter ended Dec 31, 2025, down 86.5% from $3.12 million a year earlier.
Powered by 
Analysis
Xtl Biopharmaceuticals (XTLB) Total Liabilities (2009 - 2025) Analysis & Trends
Dating back to the quarter ended Mar 31, 2009, Xtl Biopharmaceuticals' Total Liabilities record includes 66 quarters.
- Total Liabilities has a five-year compound annual growth rate of -32.0% (years ended Dec 2020 to Dec 2025).
- By year, Total Liabilities came in at $3.12 million in the year ended Dec 31, 2024, $206,000 in the year ended Dec 31, 2023 (+10.2%), $187,000 in the year ended Dec 31, 2022 (-85.4%) and $1.29 million in the year ended Dec 31, 2021 (-55.6%).
- The figure for the quarter ended Dec 31, 2025 ranks as the lowest quarterly Total Liabilities since the quarter ended Jun 30, 2024.
- Year over year, Total Liabilities gained in two of the last four quarters, with growth averaging 67.1%.
- The high point for year-over-year Total Liabilities in five years was the quarter ended Mar 31, 2021 (growth of 422.9%); the low point was the quarter ended Sep 30, 2022 (a decline of 95.9%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 116.09 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 141.05 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 87.82 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 80.09 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 65.46 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 83.95 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 37.53 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 115.64 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 7.18 Bn |
| 10 | Xtl Biopharmaceuticals | 2.11 Bn | 2.11 Bn | - | 420,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 420,000.00 |
| Jun 30, 2025 | 761,000.00 |
| Dec 31, 2024 | 3.12 Mn |
| Sep 30, 2024 | 3.56 Mn |
| Jun 30, 2024 | 165,000.00 |
| Mar 31, 2024 | 223,000.00 |
| Dec 31, 2023 | 206,000.00 |
| Sep 30, 2023 | 162,000.00 |
| Jun 30, 2023 | 163,000.00 |
| Mar 31, 2023 | 241,000.00 |
| Dec 31, 2022 | 187,000.00 |
| Sep 30, 2022 | 153,000.00 |
| Jun 30, 2022 | 194,000.00 |
| Mar 31, 2022 | 777,000.00 |
| Dec 31, 2021 | 1.29 Mn |
| Sep 30, 2021 | 3.78 Mn |
| Jun 30, 2021 | 3.67 Mn |
| Mar 31, 2021 | 2.94 Mn |
| Dec 31, 2020 | 2.89 Mn |
| Sep 30, 2020 | 182,000.00 |
API Access
Xtl Biopharmaceuticals Total Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=total-liabilities&ticker=XTLB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "total-liabilities", "ticker": "XTLB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=total-liabilities&ticker=XTLB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();